AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)

Clinical trial NCT00808249 · COMPLETED

Trial details

NCT number: NCT00808249
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anxiety Disorders

Start date: 2008-12-01
Primary completion: 2009-05-01
Enrollment: 725

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.